搜尋結果
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
Reuters· 5 日前, opens new tab said it expects its cancer drug Lorbrena to top $1 billion in annual sales by ...
Why CEO AstraZeneca believes the drugmaker can almost double revenue by 2030
CNBC· 8 小時前AstraZeneca CEO Pascal Soriot explained in a Tuesday interview with CNBC's Jim Cramer why t ...
Gaza’s doctors were building a health system. Then came war.
Reuters· 21 小時前Israel closed Gaza’s borders with Egypt’s help, curtailed people’s
Pharma Billionaire's Fortune More Than Doubles In A Day On Cancer Drug Trial News
Forbes· 5 日前The 272% surge in Summit’s stock more than doubled the fortune ...
Lung Cancer Was a Death Sentence. Now Drugs Are Saving Lives.
The Wall Street Journal· 3 日前More patients can fend off the disease for months or years with targeted or immune-boosting ...
Taiwan’s opposition gives William Lai and his DPP minority government a headache
South China Morning Post· 4 日前The opposition’s legislative package moves the Taiwanese legislature ...
China Market Update: MSCI Index Rebalance Weighs On Hong Kong, Week In Review
Forbes· 5 日前Asian equities were largely higher on high volumes driven by MSCI’s semi-index rebalance, as Japan outperformed ...